A
Atraverse Medical
Atraverse Medical develops left-heart access technology to simplify workflows and enhance patient outcomes
About Atraverse Medical
Atraverse Medical specializes in developing advanced transeptal access technologies aimed at improving the efficiency and outcomes of left heart procedures. The company operates in the medical technology sector, focusing on innovations that streamline complex cardiac procedures. Atraverse Medical primarily serves healthcare providers, including hospitals and specialized cardiac centers, who require precise and reliable tools for heart surgeries. The business model revolves around the research, development, and eventual commercialization of these medical devices, with a planned market launch in 2025. Revenue is generated through the sale of these specialized medical devices to healthcare institutions. Atraverse Medical's commitment to innovation positions it as a key player in the evolving field of cardiac surgery technology.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2023
- Headquarters
- Chicago, United States
- Employees
- 36
- Open positions
- None listed
- Dealroom signal
- 86.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Cardiology and cardiovascular, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Apr 2026 | $0 | — | Johnson & Johnson | ↗ |
| SEED✓Equity / VC | Jun 2025 | $29M | $118M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Atraverse Medical is 130 monthly website visits, down 89.2% over the last three months. Atraverse Medical's team grew 12.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Ruixin Intelligent Medical TechnologyAI-powered cardiovascular diagnosis and surgical robotics. |
Shenzhen, China | Operational | 1 | $17M | $440M |
| Hangzhou, China | Operational | ||||
| Osaka, Japan | Operational | ||||
PolyemboVessel embolization device for peripheral vascular procedures |
Longmont, United States | Operational | |||
HemaSenseEarly alert system for post-surgical bleeding complications |
Phoenix, United States | Operational | |||
| STShenzhen Saihe Medical TechnologyHealth Tech & Medtech | Ningbo, China | Operational | |||
Inquis MedicalA privately clinical stage medical device company based in Silicon Valley |
Menlo Park, United States | Operational | |||
| SDShanghai Yixin Medical DevicesHealth Tech & Medtech | China | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
Johnson & Johnson
New York Angels
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Atraverse Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Atraverse Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.



